{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:00:22Z","timestamp":1758474022253,"version":"3.44.0"},"reference-count":9,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>Central retinal artery occlusion (CRAO) is a devastating disease resulting in severe visual loss in most cases. It has no proven treatment, and a variety of management options used clinically all have dismal rate of success. We report outcome of treatment with local intra-arterial thrombolysis administered 2.75\u2009hours after devastating visual loss from incomplete CRAO.<\/jats:p>","DOI":"10.1136\/bcr-2020-234505","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T06:35:17Z","timestamp":1587018917000},"page":"e234505","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Dramatic recovery of vision in patient with acute central retinal artery occlusion treated with local intra-arterial tissue plasminogen activator"],"prefix":"10.1136","volume":"13","author":[{"given":"Edward A","family":"Margolin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrit","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill","family":"Zaslavsky","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha","family":"Kohly","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Nicholson","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"2025082800361981000_13.4.e234505.1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/aes.2018.05.04","article-title":"Acute retinal arterial ischemia","volume":"3","author":"Dattilo","year":"2018","journal-title":"Ann Eye Sci"},{"key":"2025082800361981000_13.4.e234505.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4835(03)00214-8"},{"key":"2025082800361981000_13.4.e234505.3","first-page":"443","article-title":"Central retinal artery occlusion - rethinking retinal survival time. BMC Ophthalmol. 2018 Apr 18;18(1):101. 3. Chronopoulos A, Schutz JS. Central retinal artery occlusion- a new, provisional treatment approach","volume":"64","author":"Tobalem","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"2025082800361981000_13.4.e234505.4","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.505404"},{"key":"2025082800361981000_13.4.e234505.5","doi-asserted-by":"publisher","DOI":"10.1007\/BF00588405"},{"key":"2025082800361981000_13.4.e234505.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.03.061"},{"key":"2025082800361981000_13.4.e234505.7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaneurol.2013.616","article-title":"Tissue plasminogen activator and calcific emboli","volume":"70","author":"Gokhale","year":"2013","journal-title":"JAMA Neurol"},{"key":"2025082800361981000_13.4.e234505.8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.613653"},{"key":"2025082800361981000_13.4.e234505.9","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-234505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:36:30Z","timestamp":1756366590000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-234505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,15]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/bcr-2020-234505"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-234505","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}